$80,000 of DUPONT DE NEMOURS INC. lobbying was just disclosed, from Q4 of 2025, in a new Lobbying Disclosure Act filing.
This included lobbying on issues like:
"Implementation of the CHIPS and Science Act, including the Investment Tax Credit authorized under Section 107 of the Act; One Big Beautiful Bill Act. Implementation of the CHIPS and Science Act. Implementation of the CHIPS and Science Act."
You can find more data on corporate lobbying on Quiver Quantitative.
DD Congressional Stock Trading
Members of Congress have traded $DD stock 1 times in the past 6 months. Of those trades, 0 have been purchases and 1 have been sales.
Here’s a breakdown of recent trading of $DD stock by members of Congress over the last 6 months:
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 11/12.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard.
DD Insider Trading Activity
DD insiders have traded $DD stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $DD stock by insiders over the last 6 months:
- STEVEN P. LARRABEE (SVP & CIO) has made 0 purchases and 4 sales selling 74,208 shares for an estimated $5,714,885.
- LORI KOCH (CEO) sold 9,011 shares for an estimated $355,574
- ERIK T. HOOVER (SVP & General Counsel) sold 6,005 shares for an estimated $238,938
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
DD Hedge Fund Activity
We have seen 609 institutional investors add shares of DD stock to their portfolio, and 588 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MASSACHUSETTS FINANCIAL SERVICES CO /MA/ removed 4,832,984 shares (-60.1%) from their portfolio in Q3 2025, for an estimated $376,489,453
- GOLDMAN SACHS GROUP INC added 3,246,246 shares (+129.1%) to their portfolio in Q3 2025, for an estimated $252,882,563
- VANGUARD GROUP INC added 3,203,044 shares (+6.7%) to their portfolio in Q3 2025, for an estimated $249,517,127
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC added 2,366,661 shares (+78.9%) to their portfolio in Q3 2025, for an estimated $184,362,891
- CITADEL ADVISORS LLC removed 2,278,665 shares (-88.0%) from their portfolio in Q3 2025, for an estimated $177,508,003
- INVESCO LTD. added 1,942,589 shares (+28.2%) to their portfolio in Q3 2025, for an estimated $151,327,683
- MILLENNIUM MANAGEMENT LLC added 1,758,475 shares (+469.5%) to their portfolio in Q3 2025, for an estimated $136,985,202
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
DD Analyst Ratings
Wall Street analysts have issued reports on $DD in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Keybanc issued a "Overweight" rating on 01/09/2026
- UBS issued a "Buy" rating on 01/07/2026
- RBC Capital issued a "Outperform" rating on 11/18/2025
- Wells Fargo issued a "Overweight" rating on 11/07/2025
- BMO Capital issued a "Outperform" rating on 11/03/2025
- JP Morgan issued a "Overweight" rating on 10/15/2025
To track analyst ratings and price targets for DD, check out Quiver Quantitative's $DD forecast page.
DD Price Targets
Multiple analysts have issued price targets for $DD recently. We have seen 7 analysts offer price targets for $DD in the last 6 months, with a median target of $50.0.
Here are some recent targets:
- Aleksey Yefremov from Keybanc set a target price of $51.0 on 01/09/2026
- Joshua Spector from UBS set a target price of $49.0 on 01/07/2026
- John Roberts from Mizuho set a target price of $46.0 on 12/18/2025
- Arun Viswanathan from RBC Capital set a target price of $48.0 on 11/18/2025
- Michael Sison from Wells Fargo set a target price of $50.0 on 11/07/2025
- John McNulty from BMO Capital set a target price of $50.0 on 11/03/2025
- Stephen Tusa from JP Morgan set a target price of $104.0 on 10/15/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
